Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr David Koss.

Newcastle AuthorsTitleYearFull text
Professor David Steel
Dr David Koss
Surgical classification for large macular hole: based on different surgical techniques results: the CLOSE study group2023
Dr Paul Donaghy
Dr Simon Cockell
Dr Carmen Martin-Ruiz
Dr Jonathan Coxhead
Dr Joseph Kane
et al.
Blood mRNA expression in Alzheimer’s disease and dementia with Lewy bodies2022
Dr David Koss
Dr Daniel Erskine
Dr Andrew Porter
Dr Pawel Palmowski
Professor Johannes Attems
et al.
Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.2022
Chris Hatton
Dr David Koss
Dr Lauren Walker
Professor Tiago Outeiro
Professor Johannes Attems
et al.
Prion-like α-synuclein pathology in the brain of infants with Krabbe disease2022
Dr David Koss
Professor Tiago Outeiro
Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases2021
Dr Kirsty McAleese
Mohi Miah
Dr Lauren Walker
Mary Johnson
Dr Sean Colloby
et al.
Frontal white matter lesions in Alzheimer’s disease are associated with both small vessel disease and AD-associated cortical pathology2021
Dr Daniel Erskine
Dr David Koss
Dr Viktor Korolchuk
Professor Tiago Outeiro
Professor Johannes Attems
et al.
Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders2021
Dr David Koss
Odeta Bondarevaite
Professor Johannes Attems
Professor Tiago Outeiro
RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies2021
Dr Kirsty McAleese
Dr Lauren Walker
Dr Daniel Erskine
Mary Johnson
Dr David Koss
et al.
Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden2020
Dr David Koss
Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer’s Disease2020
Dr David Koss
Professor Tiago Outeiro
Synucleinopathies: Where we are and where we need to go2020
Dr David Koss
Professor Tiago Outeiro
In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies2019
Dr David Koss
Mary Johnson
Professor Johannes Attems
Professor Tiago Outeiro
Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies2019
Professor Tiago Outeiro
Dr David Koss
Dr Daniel Erskine
Dr Lauren Walker
Abishek Umashankar
et al.
Dementia with Lewy bodies: an update and outlook2019
Dr David Koss
Pore-former enabled seeding of tau in rats: Alleviation by memantine and lithium chloride2019
Dr David Koss
Distinctive temporal profiles of detergent-soluble and -insoluble tau and Aβ species in human Alzheimer's disease2018
Dr David Koss
Alzheimer's disease pathology and the unfolded protein response: prospective pathways and therapeutic targets2017
Dr David Koss
Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology2016
Dr David Koss
Neuronal human BACE1 knockin induces systemic diabetes in mice2016
Dr David Koss
Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.2016
Dr David Koss
Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.2015
Dr David Koss
Knock-in of human BACE1 cleaves murine APP and reiterates Alzheimer-like phenotypes2014
Dr David Koss
18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's disease2013